STAT+: Merck discontinues a crucial antibiotic despite concerns over superbug resistance

Дата публикации: 28-09-2026 20:45:43

Merck discontinued Recarbio, an important antibiotic in the U.S., despite concerns over resistance to superbugs.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Blood pressure medication recalled nationwide under FDA's Class II risk level	0	6.6	28-09-2026
2	STAT+: Licensing deals on generic versions of Roche flu drug aimed at preparing for pandemic	0	10.96	25-09-2026
3	STAT+: The last ‘breakthrough’ devices to get special treatment from Medicare	0	7.35	29-09-2026
4	STAT+: Drug pricing, Medicaid, and research funding: The key policy issues at stake in the midterms	0	6.87	29-09-2026
5	OpenAI halts model release over safety concerns: "Didn't quite meet the bar"	0	8.93	29-09-2026
6	California AG cancels Paramount settlment talks over $11B Warner Bros Discovery deal, and he cites ‘a lack of good faith’	0	10	25-08-2026
7	Meta-Led Anti-Terrorism Group Faces Mass Resignation of Expert Advisers	0	14.49	28-09-2026
8	Anthropic says it thwarted plots to build biological weapons using its AI after whistleblower warned its tech will end humanity	0	5.62	10-09-2026
9	Novartis Beats Patent Listing Suit Over Entresto	0	7.9	24-09-2026
10	Jemperli (dostarlimab) accepted for priority review by the US FDA for dMMR/MSI-H locally advanced rectal cancer	0	9.74	24-08-2026

Классификация: Экономика. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5.92. Источник: www.statnews.com.